Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Total Debt (2010 - 2026)

Omeros (OMER) posted Total Debt of $52.8 million for Q1 2026, down 22.82% sequentially from $68.4 million in Q4 2025, and down 54.27% YoY from $115.5 million in Q1 2025.

Analysis

Omeros (OMER) Total Debt (2010 - 2026) Analysis & Trends

Omeros has reported Total Debt for 17 years, with the latest figure at $52.8 million in Q1 2026.

  • Quarterly Total Debt fell 54.27% year-over-year to $52.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.8 million (down 54.27% YoY) and the FY2025 annual result came in at $68.4 million, down 29.59% from the prior year.
  • Total Debt slipped to $52.8 million in Q1 2026 per OMER's latest filing, from $68.4 million in the prior quarter.
  • Over five years, Total Debt peaked at $316.7 million in Q3 2023 and troughed at $52.8 million in Q1 2026.
  • A 5-year average of $193.8 million and a median of $164.5 million in 2024 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2023 and 2024: Total Debt rose 0.61% in 2023, then slumped 70.82% in 2024.
  • Over 5 years, Total Debt stood at $315.3 million in 2022, then advanced by 0.46% to $316.7 million in 2023, then tumbled by 69.32% to $97.2 million in 2024, then dropped by 29.59% to $68.4 million in 2025, then dropped by 22.82% to $52.8 million in 2026.
  • According to Business Quant data, Total Debt over the past three periods registered $52.8 million, $68.4 million, and $72.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.34 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 42.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.03 Mn
Mar 31, 2026 52.81 Mn
Dec 31, 2025 68.43 Mn
Sep 30, 2025 104.52 Mn
Jun 30, 2025 104.33 Mn
Mar 31, 2025 115.49 Mn
Dec 31, 2024 118.18 Mn
Sep 30, 2024 97.03 Mn
Jun 30, 2024 96.89 Mn
Mar 31, 2024 213.46 Mn
Dec 31, 2023 213.16 Mn
Sep 30, 2023 316.74 Mn
Jun 30, 2023 316.25 Mn
Mar 31, 2023 315.76 Mn
Dec 31, 2022 315.29 Mn
Sep 30, 2022 314.82 Mn
Jun 30, 2022 314.36 Mn
Mar 31, 2022 313.90 Mn
Dec 31, 2021 313.46 Mn
Sep 30, 2021 313.02 Mn